Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Agnosia 6Pain 5Breast Neoplasms 3Pain, Postoperative 2Cancer Pain 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Cognitive Complications 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Chronic Pain 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Analgesics, Opioid × Clear all
NCT01541124 2018-02-08

Morphine as First Drug for Cancer Pain

Federal University of São Paulo

Phase NA Completed
60 enrolled

Cancer Pain, Agnosia, Chronic Pain

NCT01094912 2015-09-01

TALViSoP

University Hospital, Limoges

Phase NA Suspended
38 enrolled

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡